Alba E - Search Results

1

Ability of final PET/CT to predict response to first-line treatment in real patients with classical Hodgkin lymphoma.

Galvez-Carvajal L, Quero C, Casanova M, Díaz C, Chícharo JR, Espeso M, Medina Á, Ramos I, Alba E, Rueda A. Galvez-Carvajal L, et al. Among authors: alba e. Int J Hematol. 2022 Jan;115(1):54-60. doi: 10.1007/s12185-021-03223-6. Epub 2021 Sep 21. Int J Hematol. 2022. PMID: 34546542

2

Cisplatin, 5-fluorouracil, and high-dose folinic acid in patients with advanced unresectable head and neck cancer.

Alba E, Sanchez-Chaparro MA, Alonso L, Ribelles N, Ramon Delgado J, Rueda A, Pablo Tenllado P, Solano J, Urquiza R. Alba E, et al. Am J Clin Oncol. 1996 Apr;19(2):140-3. doi: 10.1097/00000421-199604000-00010. Am J Clin Oncol. 1996. PMID: 8610637 Clinical Trial.

3

Six cycles of ABVD in the treatment of stage I and II Hodgkin's lymphoma: a pilot study.

Rueda A, Alba E, Ribelles N, Sevilla I, Ruiz I, Miramón J. Rueda A, et al. Among authors: alba e. J Clin Oncol. 1997 Mar;15(3):1118-22. doi: 10.1200/JCO.1997.15.3.1118. J Clin Oncol. 1997. PMID: 9060553

4

Adjuvant anthracycline therapy as a prognostic factor in metastatic breast cancer.

Alba E, Ribelles N, Sevilla I, Rueda A, Alonso L, Marquez A, Ruiz I, Miramón J. Alba E, et al. Breast Cancer Res Treat. 2001 Mar;66(1):33-9. doi: 10.1023/a:1010616532332. Breast Cancer Res Treat. 2001. PMID: 11368408

5

Secondary prophylactic G-CSF (filgrastim) administration in chemotherapy of stage I and II Hodgkin's lymphoma with ABVD.

Rueda A, Sevilla I, Gumà J, Ribelles N, Miramón J, De Las Nieves MA, Márquez A, Alba E. Rueda A, et al. Among authors: alba e. Leuk Lymphoma. 2001 Apr;41(3-4):353-8. doi: 10.3109/10428190109057990. Leuk Lymphoma. 2001. PMID: 11378548 Clinical Trial.

6

Shift in the balance between circulating thrombospondin-1 and vascular endothelial growth factor in cancer patients: relationship to platelet alpha-granule content and primary activation.

Gonzalez FJ, Rueda A, Sevilla I, Alonso L, Villarreal V, Torres E, Alba E. Gonzalez FJ, et al. Among authors: alba e. Int J Biol Markers. 2004 Jul-Sep;19(3):221-8. Int J Biol Markers. 2004. PMID: 15503824

7

Treatment of stage I and II Hodgkin's lymphoma with ABVD chemotherapy: results after 7 years of a prospective study.

Rueda Domínguez A, Márquez A, Gumá J, Llanos M, Herrero J, de Las Nieves MA, Miramón J, Alba E. Rueda Domínguez A, et al. Among authors: alba e. Ann Oncol. 2004 Dec;15(12):1798-804. doi: 10.1093/annonc/mdh465. Ann Oncol. 2004. PMID: 15550585 Free article. Clinical Trial.

8

A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas.

Medina JA, Rueda A, de Pasos AS, Contreras J, Cobo M, Moreno P, Benavides M, Villanueva A, Alba E. Medina JA, et al. Among authors: alba e. Radiother Oncol. 2006 Apr;79(1):34-8. doi: 10.1016/j.radonc.2006.03.010. Epub 2006 Apr 19. Radiother Oncol. 2006. PMID: 16626826 Clinical Trial.

9

Treatment for relapse in stage I/II Hodgkin's lymphoma after initial single-modality treatment.

Rueda A, Olmos D, Viciana R, Alba E. Rueda A, et al. Among authors: alba e. Clin Lymphoma Myeloma. 2006 Mar;6(5):389-92. doi: 10.3816/CLM.2006.n.015. Clin Lymphoma Myeloma. 2006. PMID: 16640815

10

An uncommon presentation of non-Hodgkin's lymphoma: diffuse large-cell lymphoma presenting as a peritoneal mass.

Olmos D, Rueda A, Viciana R, Torres E, Vicioso L, Alba E. Olmos D, et al. Among authors: alba e. Leuk Lymphoma. 2006 May;47(5):933-4. doi: 10.1080/10428190500451127. Leuk Lymphoma. 2006. PMID: 16753884 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

338 results

Search Page

Filters